TABLE 1.
Percentage of samples from individuals with nonreactive, weakly reactive, or strongly reactive results by the BPX or ARC assay at weeks 12 and 24 after initiation of therapy at FI to FIV
| Assay resulta | % of samples |
|||||
|---|---|---|---|---|---|---|
| Wk 12 |
Wk 24 |
|||||
| FI | FII | FIII/IV | FI | FII | FIII/IV | |
| NR | 69.6 | 12.8 | 9.1 | 52.2 | 7.7 | 4.5 |
| S/CO < 10 | 17.4 | 56.4 | 40.9 | 34.8 | 38.5 | 36.4 |
| S/CO ≥ 10 | 13.0 | 30.8 | 50.0 | 13.0 | 53.8 | 59.1 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 |
a
NR, nonreactive (S/CO < 1.0); S/CO < 10, weakly reactive; S/CO ≥ 10, strongly reactive.